By expenditures
| Name | Title | Type |
|---|---|---|
| John Neth | Director of Grant Compliance and Finance | Auditee |
| Ashley Brandt-Duda | Partner | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 349132 | 2024 | 2025-03-27 | Eide Bailly LLP | $23.27M |
| 301691 | 2023 | 2024-04-01 | Eide Bailly LLP | $67.44M |
| 34520 | 2022 | 2023-03-27 | Eide Bailly LLP | $40.41M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 349132 | 2024 | 2025-03-27 | 1114548 | 2024-002 | Significant Deficiency | - | AB |
| 349132 | 2024 | 2025-03-27 | 1114547 | 2024-001 | Significant Deficiency | - | ABH |
| 349132 | 2024 | 2025-03-27 | 1114546 | 2024-001 | Significant Deficiency | - | AB |
| 349132 | 2024 | 2025-03-27 | 538106 | 2024-002 | Significant Deficiency | - | AB |
| 349132 | 2024 | 2025-03-27 | 538105 | 2024-001 | Significant Deficiency | - | ABH |
| 349132 | 2024 | 2025-03-27 | 538104 | 2024-001 | Significant Deficiency | - | AB |
| 301691 | 2023 | 2024-04-01 | 967541 | 2023-006 | Significant Deficiency | - | AB |
| 301691 | 2023 | 2024-04-01 | 967540 | 2023-005 | Significant Deficiency | - | AB |
| 301691 | 2023 | 2024-04-01 | 967539 | 2023-005 | Significant Deficiency | - | AB |
| 301691 | 2023 | 2024-04-01 | 967538 | 2023-005 | Significant Deficiency | - | AB |
| 301691 | 2023 | 2024-04-01 | 967537 | 2023-005 | Significant Deficiency | - | AB |
| 301691 | 2023 | 2024-04-01 | 967536 | 2023-005 | Significant Deficiency | - | AB |
| 301691 | 2023 | 2024-04-01 | 967535 | 2023-005 | Significant Deficiency | - | AB |
| 301691 | 2023 | 2024-04-01 | 967534 | 2023-005 | Significant Deficiency | - | AB |
| 301691 | 2023 | 2024-04-01 | 967533 | 2023-005 | Significant Deficiency | - | AB |
| 301691 | 2023 | 2024-04-01 | 967532 | 2023-005 | Significant Deficiency | - | AB |
| 301691 | 2023 | 2024-04-01 | 967531 | 2023-005 | Significant Deficiency | - | AB |
| 301691 | 2023 | 2024-04-01 | 967530 | 2023-005 | Significant Deficiency | - | AB |
| 301691 | 2023 | 2024-04-01 | 967529 | 2023-005 | Significant Deficiency | - | AB |
| 301691 | 2023 | 2024-04-01 | 967528 | 2023-005 | Significant Deficiency | - | AB |
| 301691 | 2023 | 2024-04-01 | 967527 | 2023-005 | Significant Deficiency | - | AB |
| 301691 | 2023 | 2024-04-01 | 967526 | 2023-005 | Significant Deficiency | - | AB |
| 301691 | 2023 | 2024-04-01 | 967525 | 2023-004 | Significant Deficiency | - | AB |
| 301691 | 2023 | 2024-04-01 | 967524 | 2023-003 | Significant Deficiency | - | ABH |
| 301691 | 2023 | 2024-04-01 | 967523 | 2023-002 | Material Weakness | - | P |
| 301691 | 2023 | 2024-04-01 | 391099 | 2023-006 | Significant Deficiency | - | AB |
| 301691 | 2023 | 2024-04-01 | 391098 | 2023-005 | Significant Deficiency | - | AB |
| 301691 | 2023 | 2024-04-01 | 391097 | 2023-005 | Significant Deficiency | - | AB |
| 301691 | 2023 | 2024-04-01 | 391096 | 2023-005 | Significant Deficiency | - | AB |
| 301691 | 2023 | 2024-04-01 | 391095 | 2023-005 | Significant Deficiency | - | AB |
| 301691 | 2023 | 2024-04-01 | 391094 | 2023-005 | Significant Deficiency | - | AB |
| 301691 | 2023 | 2024-04-01 | 391093 | 2023-005 | Significant Deficiency | - | AB |
| 301691 | 2023 | 2024-04-01 | 391092 | 2023-005 | Significant Deficiency | - | AB |
| 301691 | 2023 | 2024-04-01 | 391091 | 2023-005 | Significant Deficiency | - | AB |
| 301691 | 2023 | 2024-04-01 | 391090 | 2023-005 | Significant Deficiency | - | AB |
| 301691 | 2023 | 2024-04-01 | 391089 | 2023-005 | Significant Deficiency | - | AB |
| 301691 | 2023 | 2024-04-01 | 391088 | 2023-005 | Significant Deficiency | - | AB |
| 301691 | 2023 | 2024-04-01 | 391087 | 2023-005 | Significant Deficiency | - | AB |
| 301691 | 2023 | 2024-04-01 | 391086 | 2023-005 | Significant Deficiency | - | AB |
| 301691 | 2023 | 2024-04-01 | 391085 | 2023-005 | Significant Deficiency | - | AB |
| 301691 | 2023 | 2024-04-01 | 391084 | 2023-005 | Significant Deficiency | - | AB |
| 301691 | 2023 | 2024-04-01 | 391083 | 2023-004 | Significant Deficiency | - | AB |
| 301691 | 2023 | 2024-04-01 | 391082 | 2023-003 | Significant Deficiency | - | ABH |
| 301691 | 2023 | 2024-04-01 | 391081 | 2023-002 | Material Weakness | - | P |
| 34520 | 2022 | 2023-03-27 | 615869 | 2022-002 | Significant Deficiency | Yes | AB |
| 34520 | 2022 | 2023-03-27 | 39427 | 2022-002 | Significant Deficiency | Yes | AB |